Incidence of peritonitis in chronic peritoneal dialysis patients infused with intravenous iron dextran

Peritoneal Dialysis International

Volumn 20, Issue 6, 2001, Pages 674-678

  Allen, J R ^a   Troidle, L K ^a   Juergensen, P H ^a   Kliger, A S ^a   Finkelstein, F O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intravenous iron dextran; Peritonitis

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; IRON DEXTRAN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; BACTERIAL PERITONITIS; BOLUS INJECTION; CONTROLLED STUDY; DRUG INFUSION; DRUG TOLERABILITY; FERRITIN BLOOD LEVEL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; IRON THERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; OUTPATIENT; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TRANSFERRIN BLOOD LEVEL;

EID: 0035110575     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000616     Document Type: Article

References (23)

1. Iron management in end-stage renal disease
2. Iron deficiency in patients with renal failure
3. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
4. Clinical practice guidelines for the treatment of anemia of chronic renal failure: Iron support
5. Iron uptake mechanisms of pathogenic bacteria
6. Iron and infection
7. Pathobiology of the role of iron in infection
8. Review of issues relating to iron and infection
9. Challenges of managing chronic peritoneal dialysis-associated peritonitis
10. Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients
11. Continuous cycler therapy, manual peritoneal dialysis therapy, and peritonitis
12. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency
13. Low iron absorption in the erythropoietin-treated hemodialysis patients
14. Oral iron absorption in hemodialysis patients treated with erythropoietin
15. Iron status and supplementation in peritoneal dialysis patients
16. Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin
17. Iron acquisition from Pseudomonas aeruginosa siderophores by human phagocytes: An additional mechanism of host defense through iron sequestration?
18. The Staphylococcus aureus and Staphylococcus epidermidis transferrin-binding proteins are expressed in vivo during infection
19. Staphylococci express a receptor for human transferrin: Identification of a 42-kilodalton cell wall transferrin-binding protein
20. Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa
21. ITDI is the preferred treatment for iron supplementation in rHuEPO-treated anemic PD patients
22. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies
23. Intravenous (IV) iron for the Rx of anemia in CPD patients